AstraZeneca CEO Pascal Soriot (credit: TASS)

Does As­traZeneca CEO Pas­cal So­ri­ot re­al­ly want to merge with Gilead? A Bloomberg sto­ry sug­gests he was in­ter­est­ed — but it's hard to see why

Pas­cal So­ri­ot has ev­i­dent­ly been think­ing big.

Com­plete­ly out of left field, Bloomberg to­day post­ed a sto­ry ear­ly Sun­day say­ing that As­traZeneca ex­ecs have ap­proached Gilead to see if the big biotech would be in­ter­est­ed in join­ing up in a his­toric bio­phar­ma merg­er. No num­bers have been men­tioned yet, and no de­ci­sions have been made. Right now, ac­cord­ing to the busi­ness news ser­vice, it’s time to check every­one’s tem­per­a­ture.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.